Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (1071-1080 of 1,298) with videos related to

Pageof 130
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivoFiona Simpkins, Pedro Hevia-Paez, Jun Sun, et al.
The Journal of Investigative Dermatology|March 5, 2023
Multiplatform Analysis of Intratumoral PTEN Heterogeneity in MelanomaSharmeen Chagani, Mariana P De Macedo, Fernando Carapeto, et al.
Breast Cancer Research and Treatment|August 8, 2019
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastasesZhe-Bin Liu, Nader E Ezzedine, Agda K Eterovic, et al.
Journal of the National Cancer Institute|November 7, 2017
Comprehensive Characterization of Alternative Polyadenylation in Human CancerYu Xiang, Youqiong Ye, Yanyan Lou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerRoshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2019
COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent MechanismsAntje Lindemann, Ameeta A Patel, Natalie L Silver, et al.
Journal of the National Cancer Institute|February 18, 2015
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancerAna M Gonzalez-Angulo, Ian Krop, Argun Akcakanat, et al.
Oncotarget|March 2, 2018
Distinct histone modifications denote early stress-induced drug tolerance in cancerAbdullah Al Emran, Diego M Marzese, Dinoop Ravindran Menon, et al.
Oncotarget|May 28, 2015
Clinical next generation sequencing to identify actionable aberrations in a phase I programGenevieve M Boland, Sarina A Piha-Paul, Vivek Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2020
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant MelanomaCharles Marusak, Varsha Thakur, Yuan Li, et al.
Pageof 130

Showing results (1071-1080 of 1,298) with videos related to

Sort By:
Pageof 130
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivoFiona Simpkins, Pedro Hevia-Paez, Jun Sun, et al.
The Journal of Investigative Dermatology|March 5, 2023
Multiplatform Analysis of Intratumoral PTEN Heterogeneity in MelanomaSharmeen Chagani, Mariana P De Macedo, Fernando Carapeto, et al.
Breast Cancer Research and Treatment|August 8, 2019
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastasesZhe-Bin Liu, Nader E Ezzedine, Agda K Eterovic, et al.
Journal of the National Cancer Institute|November 7, 2017
Comprehensive Characterization of Alternative Polyadenylation in Human CancerYu Xiang, Youqiong Ye, Yanyan Lou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerRoshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2019
COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent MechanismsAntje Lindemann, Ameeta A Patel, Natalie L Silver, et al.
Journal of the National Cancer Institute|February 18, 2015
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancerAna M Gonzalez-Angulo, Ian Krop, Argun Akcakanat, et al.
Oncotarget|March 2, 2018
Distinct histone modifications denote early stress-induced drug tolerance in cancerAbdullah Al Emran, Diego M Marzese, Dinoop Ravindran Menon, et al.
Oncotarget|May 28, 2015
Clinical next generation sequencing to identify actionable aberrations in a phase I programGenevieve M Boland, Sarina A Piha-Paul, Vivek Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2020
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant MelanomaCharles Marusak, Varsha Thakur, Yuan Li, et al.
Pageof 130